Gry Festervoll
About Gry Festervoll
Gry Festervoll is the Medical Manager Immuno-Oncology at Bristol-Myers Squibb, with over 20 years of experience in the pharmaceutical and biotechnology industries.
Current Title and Position
Gry Festervoll currently holds the position of Medical Manager Immuno-Oncology at Bristol-Myers Squibb. Her role involves overseeing medical initiatives and projects related to immuno-oncology, contributing to the advancement of cancer treatments.
Previous Roles and Experience
Gry Festervoll has over 20 years of experience in the pharmaceutical and biotechnology industries. She has a diverse background in medical affairs and drug safety, having worked in various global pharmaceutical companies. She served as a Senior Scientific Global Communication Manager at BASF in Oslo, Norway from 2014 to 2016. Prior to that, she was a Medical Affairs Manager at Pronova BioPharma from 2009 to 2014, and at Sanofi from 2005 to 2009. Earlier in her career, she worked as a Medical Affairs Officer at Sanofi from 2003 to 2005, a Clinical Safety Scientist at GSK in London from 2002 to 2003, and a Drug Safety Scientist at Eli Lilly from 2001 to 2002.
Education and Qualifications
Gry Festervoll has a strong academic background with a Master of Science degree from the Babraham Institute in Cambridge, UK, completed in 2001. She also holds another Master of Science degree from the University of Oslo (UiO), which she pursued from 1994 to 2001.
Specialization in Medical Affairs and Drug Safety
Throughout her career, Gry Festervoll has specialized in medical affairs and drug safety. Her roles have spanned from managing clinical safety at GSK to overseeing medical affairs at Sanofi and Pronova BioPharma. This extensive experience has equipped her with a robust understanding of scientific communication and the complexities involved in drug safety and medical management.
Involvement in Immuno-Oncology
Since at least 2020, Gry Festervoll has been involved in the field of immuno-oncology. In her current role at Bristol-Myers Squibb, she focuses on medical initiatives related to immuno-oncology, a cutting-edge field aimed at harnessing the immune system to combat cancer.